search
Back to results

Electrophysiological Effects of Late PCI After MI

Primary Purpose

Cardiovascular Diseases, Heart Diseases, Myocardial Infarction

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PCI
Optimal Medical Therapy
Sponsored by
University of Maryland, Baltimore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiovascular Diseases focused on measuring Stents, myocardial infarction

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Has experienced a heart attack 3 to 28 days prior to study entry Persistently occluded IRA defined as either: 1) Thrombolysis in Myocardial Infarction (TIMI) 0, with no flow beyond the site of occlusion; or 2) TIMI 1, with penetration of dye beyond the site of occlusion without dye reaching the distal vessel LVEF less than 50% or proximal occlusion in a large vessel Normal sinus rhythm QRS duration less than 120 ms Able to return for follow-up assessment of arrhythmia markers one month and one year after study entry Exclusion Criteria: Has a clinical indication for revascularization (post-heart attack angina at rest; significant inducible ischemia; or significant left main or triple vessel disease requiring PTCA or CABG) Current serious illness or condition that limits 3-year survival Severe valvular disease Chronic total occlusion New York Heart Association Class III-IV congestive heart failure Prior left ventricular aneurysm in the recent heart attack location Is a poor candidate for PTCA/stent on the basis of angiographic or clinical criteria Cannot medically survive anticoagulation during PTCA/stent or antiplatelet therapy after stent Pregnant

Sites / Locations

  • Stony Brook University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

PCI+MED

MED

Arm Description

Percutaneous Coronary Intervention (PCI) with angioplasty and stenting of the infarct-related artery and optimal medical therapy

Optimal medical therapy alone

Outcomes

Primary Outcome Measures

Short-termed Fractal Scaling Exponent (Alpha 1)
Nonlinear measurement of heart rate variability, change between baseline and 1 year is the primary outcome.

Secondary Outcome Measures

T-wave Variability
Variability in T wave morphology, change between baseline and one year
Filtered QRS Duration
Signal-averaged ECG

Full Information

First Posted
July 6, 2005
Last Updated
May 16, 2022
Sponsor
University of Maryland, Baltimore
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00119847
Brief Title
Electrophysiological Effects of Late PCI After MI
Official Title
Electrophysiological Effects of Late PCI (OAT-EP)
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
September 2002 (Actual)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if opening blocked arteries with heart balloons and stents prevents heart rhythm problems in individuals 3 to 28 days after a heart attack.
Detailed Description
BACKGROUND: There is now unequivocal evidence that early coronary reperfusion using either thrombolytics or primary angioplasty results in a long-term mortality reduction among individuals who have had a heart attack. The benefit of early reperfusion (less than 6 hours after the heart attack) was initially attributed to myocardial salvage and the resultant preservation of left ventricular function. However, it is now known that the survival benefit associated with thrombolytic therapy is not consistently associated with a major improvement in left ventricular ejection fraction (LVEF). These observations led to the formulation of the "late open artery hypothesis," which suggests that clinical outcomes can potentially be improved by late reperfusion after a heart attack. Observational clinical studies have suggested that late patency of the infarct-related artery (IRA) after thrombolysis is associated with a survival benefit that is independent of LVEF and therefore cannot be solely explained by salvage of myocardium. Definitive proof of the late open artery hypothesis is currently lacking, however, because previous studies that have evaluated late percutaneous transluminal coronary angioplasty (PTCA) of occluded IRAs after a heart attack have produced conflicting results. These findings led to the organization of the Occluded Artery Trial (OAT), an international, NHLBI-funded, randomized trial of 2,200 participants. OAT is testing the hypothesis that mechanical reperfusion of an occluded IRA with PTCA and percutaneous coronary intervention (PCI) 3 to 28 days after a heart attack in high-risk individuals will reduce mortality, recurrent heart attacks, and hospitalization for class IV congestive heart failure. Enhancement of electrical stability is one of the major mechanisms that has been proposed to explain the association of an open IRA with an improved prognosis independent of myocardial salvage. DESIGN NARRATIVE: This study is an ancillary study of OAT. It will characterize the effects of late PCI of occluded IRAs on the most important and clinically relevant noninvasive markers of vulnerability to malignant ventricular arrhythmias: heart rate variability, T wave variability, and signal-averaged electrocardiography. These analyses will be performed in 300 participants at baseline, 30 days, and 1 year following a heart attack in order to determine the effects of late PCI on the autonomic nervous system, ventricular repolarization, and ventricular conduction abnormalities.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Coronary Disease, Arrhythmia, Ventricular Fibrillation
Keywords
Stents, myocardial infarction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PCI+MED
Arm Type
Experimental
Arm Description
Percutaneous Coronary Intervention (PCI) with angioplasty and stenting of the infarct-related artery and optimal medical therapy
Arm Title
MED
Arm Type
Experimental
Arm Description
Optimal medical therapy alone
Intervention Type
Procedure
Intervention Name(s)
PCI
Other Intervention Name(s)
Angioplasty and stenting of the infarct-related artery
Intervention Type
Drug
Intervention Name(s)
Optimal Medical Therapy
Intervention Description
Guideline-directed drug therapies after MI
Primary Outcome Measure Information:
Title
Short-termed Fractal Scaling Exponent (Alpha 1)
Description
Nonlinear measurement of heart rate variability, change between baseline and 1 year is the primary outcome.
Time Frame
Baseline, one year
Secondary Outcome Measure Information:
Title
T-wave Variability
Description
Variability in T wave morphology, change between baseline and one year
Time Frame
Baseline and one year
Title
Filtered QRS Duration
Description
Signal-averaged ECG
Time Frame
Baseline and one year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Has experienced a heart attack 3 to 28 days prior to study entry Persistently occluded IRA defined as either: 1) Thrombolysis in Myocardial Infarction (TIMI) 0, with no flow beyond the site of occlusion; or 2) TIMI 1, with penetration of dye beyond the site of occlusion without dye reaching the distal vessel LVEF less than 50% or proximal occlusion in a large vessel Normal sinus rhythm QRS duration less than 120 ms Able to return for follow-up assessment of arrhythmia markers one month and one year after study entry Exclusion Criteria: Has a clinical indication for revascularization (post-heart attack angina at rest; significant inducible ischemia; or significant left main or triple vessel disease requiring PTCA or CABG) Current serious illness or condition that limits 3-year survival Severe valvular disease Chronic total occlusion New York Heart Association Class III-IV congestive heart failure Prior left ventricular aneurysm in the recent heart attack location Is a poor candidate for PTCA/stent on the basis of angiographic or clinical criteria Cannot medically survive anticoagulation during PTCA/stent or antiplatelet therapy after stent Pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric J. Rashba, MD
Organizational Affiliation
Stony Brook University Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Stony Brook University Medical Center
City
Stony Brook
State/Province
New York
ZIP/Postal Code
11794
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
15149425
Citation
Rashba EJ. Assessment of ventricular repolarization abnormalities in congenital long QT syndrome. J Cardiovasc Electrophysiol. 2004 May;15(5):557-9. doi: 10.1046/j.1540-8167.2004.04022.x. No abstract available.
Results Reference
background
PubMed Identifier
15851311
Citation
Rashba EJ. Should T-wave alternans testing be used to risk stratify candidates for prophylactic implantable cardioverter-defibrillator therapy? Heart Rhythm. 2005 Mar;2(3):242-4. doi: 10.1016/j.hrthm.2004.12.015. No abstract available.
Results Reference
background
PubMed Identifier
19188505
Citation
Rashba EJ, Lamas GA, Couderc JP, Hollist SM, Dzavik V, Ruzyllo W, Fridrich V, Buller CE, Forman SA, Kufera JA, Carvalho AC, Hochman JS; OAT-EP Investigators. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP). Circulation. 2009 Feb 17;119(6):779-87. doi: 10.1161/CIRCULATIONAHA.108.808626. Epub 2009 Feb 2.
Results Reference
result

Learn more about this trial

Electrophysiological Effects of Late PCI After MI

We'll reach out to this number within 24 hrs